Expanding Market Presence Pelion S.A. operates across Poland, Lithuania, and the UK, serving diverse segments including wholesale, retail, hospitals, and manufacturers. This geographical and segment diversification offers opportunities to tailor sales efforts to various healthcare providers and institutions in multiple regions.

Recent Investment Boost The €25 million investment from the European Bank for Reconstruction and Development signifies strong growth potential and investor confidence, indicating a favorable environment for partnership or sales collaborations to support further expansion or product innovation.

Financial Growth Potential With revenues ranging from $1 million to $10 million and recent funding, Pelion S.A. presents a promising target for pharmaceutical suppliers and service providers aiming to partner with mid-sized companies with growth ambitions in Central and Eastern Europe.

Technology Adoption Pelion’s use of advanced digital tools such as DocuSign and Highcharts demonstrates a commitment to modern, efficient processes, creating opportunities for sales of digital solutions, healthcare IT, and process automation services.

Industry Positioning As part of one of the largest healthcare groups in Poland with a presence in multiple countries, Pelion S.A. provides a strategic entry point for companies seeking to expand into Central European pharmaceutical markets through partnerships or supply chain collaborations.